Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Obstructive Lung Diseases

  Free Subscription

Articles published in Chest

Retrieve available abstracts of 115 articles:
HTML format

Single Articles

    November 2022
  1. CAZES N, Briquet A
    COPD Risk After Military Service: Let's Go Further Before Concluding.
    Chest. 2022;162:e287-e288.

  2. SMITH KS, Lee SA, Albers BK, Stevens EL, et al
    A 13-Year-Old Male Patient With Severe Multifocal Pneumonia and Bronchiectasis That Required Extracorporeal Membrane Oxygenation.
    Chest. 2022;162:e265-e271.
    PubMed     Abstract available

  3. KEIR HR, Chalmers JD
    COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No.
    Chest. 2022;162:972-976.

  4. MARTINEZ-GARCIA MA, Alvar Agusti
    POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes.
    Chest. 2022;162:970-972.

  5. CHO EE, Gershon AS
    Single vs Multiple Inhaler Triple Therapy in the COPD Population.
    Chest. 2022;162:947-948.

  6. ALCAZAR-NAVARRETE B, Jamart L, Sanchez-Covisa J, Juarez M, et al
    Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
    Chest. 2022;162:1017-1029.
    PubMed     Abstract available

  7. NEDER JA, Kirby M, Santyr G, Pourafkari M, et al
    V/Q Mismatch: A Novel Target for COPD Treatment.
    Chest. 2022;162:1030-1047.
    PubMed     Abstract available

    October 2022
  8. MAKRINIOTI H, Camargo CA Jr, Jartti T, Hasegawa K, et al
    Toward Precision Epidemiology in Bronchiolitis.
    Chest. 2022;162:744-746.

  9. TRUPIN L, Schmajuk G, Ying D, Yelin E, et al
    Military Service and COPD Risk.
    Chest. 2022;162:792-795.

    September 2022
  10. ZAKRAJSEK JK, Min SJ, Ho PM, Kiser TH, et al
    Extracorporeal Membrane Oxygenation (ECMO) for Refractory Asthma Exacerbations with Respiratory Failure.
    Chest. 2022 Sep 30. pii: S0012-3692(22)03899-5. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available

  11. KHASAWNEH M, Leon ME, Urbine D
    A 65-Year-Old Woman With Intractable Cough.
    Chest. 2022;162:e123-e126.
    PubMed     Abstract available

  12. SODHI A, Pisani M, Glassberg MK, Bourjeily G, et al
    Sex and Gender in Lung Disease and Sleep Disorders: A State-of-the-Art Review.
    Chest. 2022;162:647-658.
    PubMed     Abstract available

  13. DIAZ DEL VALLE F, Zakrajsek JK, Min SJ, Koff PB, et al
    Impact of Airline Secondhand Tobacco Smoke Exposure on Respiratory Health and Lung Function Decades After Exposure Cessation.
    Chest. 2022;162:556-568.
    PubMed     Abstract available

    August 2022
  14. VICENDESE D, Yerkovich S, Grimwood K, Valery PC, et al
    Long-term azithromycin in children with bronchiectasis unrelated to cystic fibrosis: treatment effects over time.
    Chest. 2022 Aug 25. pii: S0012-3692(22)03684.
    PubMed     Abstract available

  15. SHAFIQ M, Polhemus E, Perkins R, Forth V, et al
    Bilateral Bronchoscopic Lung Volume Reduction After Surgical Fissure Completion.
    Chest. 2022;162:e73-e75.
    PubMed     Abstract available

  16. ATWOOD CE, Bhutani M, Ospina MB, Rowe BH, et al
    Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator: A Randomized Clinical Trial.
    Chest. 2022;162:321-330.
    PubMed     Abstract available

    July 2022
  17. GUAN WJ, Xu JF, Luo H, Xu XX, et al
    A Double-blind Randomized Placebo-controlled Phase-3 Trial of Tobramycin Inhalation Solution in Adults with Bronchiectasis with Pseudomonas aeruginosa Infection.
    Chest. 2022 Jul 18. pii: S0012-3692(22)01247-8. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available

  18. HAHN DL
    Azithromycin Response in Uncontrolled Asthma in Children: Binary or Continuous?
    Chest. 2022;162:e61.

  19. LUGOGO N, Mohan A
    Are We Poised to Change the Trajectory of Maintenance Oral Corticosteroid Use in Severe Asthma in the Age of Biologics?
    Chest. 2022;162:4-5.

  20. THOMAS D, Gibson PG
    Long-Term, Low-Dose Azithromycin for Uncontrolled Asthma in Children.
    Chest. 2022;162:27-29.

  21. SPRUIT MA, Tan WC
    Physical Frailty Makes Matters Worse in People With COPD.
    Chest. 2022;162:25-26.

  22. GUERRA S
    Nonobstructive Chronic Bronchitis: A Sentinel for Risk of Premature Death in Smokers?
    Chest. 2022;162:19-21.

  23. KANJ AN, Ryu JH
    Severe Airflow Obstruction From Constrictive (Obliterative) Bronchiolitis in Paraneoplastic Autoimmune Multiorgan Syndrome.
    Chest. 2022;162:179-183.

  24. FORTIS S, Shannon ZK, Garcia CJ, Guillamet RV, et al
    Association of Nonobstructive Chronic Bronchitis With All-Cause Mortality: A Systematic Literature Review and Meta-analysis.
    Chest. 2022;162:92-100.
    PubMed     Abstract available

  25. CHERIAN SV, Patel D, Machnicki S, Naidich D, et al
    Algorithmic Approach to the Diagnosis of Organizing Pneumonia: A Correlation of Clinical, Radiologic, and Pathologic Features.
    Chest. 2022;162:156-178.
    PubMed     Abstract available

  26. HUG S, Cavalheri V, Gucciardi DF, Hill K, et al
    An Evaluation of Factors That Influence Referral to Pulmonary Rehabilitation Programs Among People With COPD.
    Chest. 2022;162:82-91.
    PubMed     Abstract available

    June 2022
  27. VAES AW, Spruit MA, Koolen EH, Antons JC, et al
    "Can Do, Do Do" Quadrants and 6-Year All-Cause Mortality in Patients With COPD.
    Chest. 2022;161:1494-1504.
    PubMed     Abstract available

    May 2022
  28. SINGH J, Randev S, Kumar P, Mahajan V, et al
    A 16-Year-Old-Girl With Asthma, Palpable Purpura, and Hypereosinophilia.
    Chest. 2022;161:e305-e308.
    PubMed     Abstract available

  29. HUDLER AC, Sharma S
    Understanding the Genetics of Asthma-COPD Overlap.
    Chest. 2022;161:1125-1126.

  30. LEE SY, Nyunt MSZ, Gao Q, Gwee X, et al
    Co-occurrence of Physical Frailty and COPD and Association With Disability and Mortality: Singapore Longitudinal Ageing Study.
    Chest. 2022;161:1225-1238.
    PubMed     Abstract available

  31. ESTHER CR JR, O'Neal WK, Anderson WH, Kesimer M, et al
    Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.
    Chest. 2022;161:1239-1249.
    PubMed     Abstract available

  32. IYER AS, Sullivan DR, Lindell KO, Reinke LF, et al
    The Role of Palliative Care in COPD.
    Chest. 2022;161:1250-1262.
    PubMed     Abstract available

    April 2022
  33. CLARK SM, Parker AM, Ataya A
    A 31-Year-Old Man With Asthma, Chest Discomfort, and Shortness of Breath.
    Chest. 2022;161:e209-e212.
    PubMed     Abstract available

  34. PAUL TK, Kim JS
    Can Interstitial Lung Abnormalities Explain a High FVC in a Smoker With Emphysema?
    Chest. 2022;161:872-873.

  35. YAWN BP
    Developing and Disseminating Evidence to Support Enhanced Spirometry Use in Primary Care Diagnosis of Asthma and COPD.
    Chest. 2022;161:865-866.

    Classification of Small Airways.
    Chest. 2022;161:e249.

  37. MASON SE, Moreta-Martinez R, Labaki WW, Strand MJ, et al
    Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers.
    Chest. 2022;161:960-970.
    PubMed     Abstract available

  38. YEE N, Markovic D, Buhr RG, Fortis S, et al
    Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.
    Chest. 2022;161:949-959.
    PubMed     Abstract available

    March 2022
  39. MCINTOSH MJ, Kooner HK, Eddy RL, Jeimy S, et al
    Asthma control, Airway mucus and (129)Xe MRI ventilation after a single Benralizumab dose.
    Chest. 2022 Mar 10. pii: S0012-3692(22)00424-X. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available

  40. MOSS MH, Lugogo NL, Castro M, Hanania NA, et al
    Results of a phase 2b trial with GB001, a DP2 antagonist, in moderate-to-severe eosinophilic asthma.
    Chest. 2022 Mar 3. pii: S0012-3692(22)00405-6. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available

  41. Correction to Figure in: Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
    Chest. 2022;161:863.

  42. NOLAN CM, Polgar O, Schofield SJ, Patel S, et al
    Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study.
    Chest. 2022;161:728-737.
    PubMed     Abstract available

  43. WAN ES, Hokanson JE, Regan EA, Young KA, et al
    Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
    Chest. 2022;161:651-661.
    PubMed     Abstract available

  44. WOUTERS EFM, Breyer-Kohansal R
    Spirometry: The Indefinite Search for Gold.
    Chest. 2022;161:593-594.

  45. ROSE EK, O'Connor J
    Addressing Advance Care Planning in Patients With COPD.
    Chest. 2022;161:676-683.
    PubMed     Abstract available

  46. SYED N, Ryu MH, Dhillon S, Schaeffer MR, et al
    Effects of Traffic-Related Air Pollution on Exercise Endurance, Dyspnea, and Cardiorespiratory Responses in Health and COPD: A Randomized, Placebo-Controlled, Crossover Trial.
    Chest. 2022;161:662-675.
    PubMed     Abstract available

    February 2022
  47. GARNER O, Ramey JS, Hanania NA
    Management of Life-Threatening Asthma: Severe Asthma Series.
    Chest. 2022 Feb 23. pii: S0012-3692(22)00395-6. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available

  48. SHER LD, Wechsler ME, Rabe KF, Maspero JF, et al
    Dupilumab reduces oral corticosteroid use in patients with corticosteroid-dependent severe asthma: An analysis of the phase 3, open-label extension TRAVERSE trial.
    Chest. 2022 Feb 22. pii: S0012-3692(22)00388-9. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available

  49. GHIMIRE JJ, Jat KR, Sankar J, Lodha R, et al
    Azithromycin for Poorly Controlled Asthma in Children: A randomized controlled trial.
    Chest. 2022 Feb 21. pii: S0012-3692(22)00293-8. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available

  50. VAMEGHESTAHBANATI M, Hiura GT, Barr RG, Sieren JC, et al
    CT-Assessed Dysanapsis and Airflow Obstruction in Early and Mid Adulthood.
    Chest. 2022;161:389-391.

    January 2022
  51. JOHN C, Guyatt AL, Shrine N, Packer R, et al
    Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap.
    Chest. 2022 Jan 29. pii: S0012-3692(22)00198-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  52. KOVACS G, Avian A, Bachmaier G, Troester N, et al
    Severe pulmonary hypertension in COPD - impact on survival and diagnostic approach.
    Chest. 2022 Jan 26. pii: S0012-3692(22)00192-1. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available

  53. SURI R, Macinko J, Inkelas M, Needleman J, et al
    The relationship between insurance status and the Affordable Care Act on asthma outcomes among low-income US adults.
    Chest. 2022 Jan 15. pii: S0012-3692(22)00046-0. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available

  54. CHIAPPETTA M, Sassorossi C, Lococo F, Lorusso R, et al
    Intrapleural Foreign Body in a Critically Ill Patient: What Can We Do?
    Chest. 2022;161:e51-e53.

  55. MAJUMDAR U, Hatipoglu U, Stoller JK
    A 21-Year-Old Man With Dyspnea, Wheezing, and Cough.
    Chest. 2022;161:e13-e17.
    PubMed     Abstract available

    December 2021
  56. AZAM MB, Chhabra S, Agrawal S, Sharma P, et al
    A 37-Year-Old Man With Bronchial Asthma and Unexplained Hypoxemia.
    Chest. 2021;160:e633-e638.
    PubMed     Abstract available

  57. HILL K, Dolmage TE
    Take a Deep Breath: More Support for Noninvasive Ventilation During Exercise in People With COPD.
    Chest. 2021;160:1991-1992.

  58. DENNIS CJ, Menadue C, Schneeberger T, Leitl D, et al
    Bilevel Noninvasive Ventilation During Exercise Reduces Dynamic Hyperinflation and Improves Cycle Endurance Time in Severe to Very Severe COPD.
    Chest. 2021;160:2066-2079.
    PubMed     Abstract available

  59. BURTIN C, Mohan D, Troosters T, Watz H, et al
    Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.
    Chest. 2021;160:2080-2100.
    PubMed     Abstract available

    November 2021
  60. PINSKY PF, Lynch DA, Gierada DS
    Incidental Findings on Low-Dose CT Lung Cancer Screenings and Deaths from Respiratory Diseases.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04413-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  61. HULL RC, Huang JT, Barton AK, Keir HR, et al
    Sputum Proteomics in non-Tuberculous Mycobacterial Lung Disease.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04412-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  62. CHUPP G, Kline JN, Khatri SB, McEvoy C, et al
    Bronchial Thermoplasty in Severe Asthmatics At 5 Years: The PAS2 Study.
    Chest. 2021 Nov 10. pii: S0012-3692(21)04274-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  63. MENON AA, Putman RK, Sanders JL, Hino T, et al
    Interstitial Lung Abnormalities, Emphysema and Spirometry in Smokers.
    Chest. 2021 Nov 3. pii: S0012-3692(21)04260-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  64. YAMADA J, Shin Cheung JL, Gagne M, Spiegel-Feld C, et al
    Barriers and Enablers to Objective Testing for Asthma and COPD in Primary Care: A Systematic Review Using the Theoretical Domains Framework.
    Chest. 2021 Nov 2. pii: S0012-3692(21)04256-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  65. BARN P, Rideout KL, Lo W, Josey D, et al
    Better together: Launching and nurturing a Community Stakeholder Committee to enhance care and research for asthma and COPD.
    Chest. 2021 Nov 2. pii: S0012-3692(21)04254-9. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  66. GOEL K, Maleki-Fischbach M, George MP, Kim D, et al
    A 56-Year-Old Man With Emphysema, Rash, and Arthralgia.
    Chest. 2021;160:e513-e518.
    PubMed     Abstract available

  67. OKEREKE J, Malin M, Koo P
    A 31-Year-Old Pregnant Woman With Asthma, Presenting With Worsening Dyspnea, Wheeze, and Hoarseness.
    Chest. 2021;160:e507-e512.
    PubMed     Abstract available

  68. Correction to Funding/Support in: International Severe Asthma Registry: Mission Statement.
    Chest. 2021;160:1989.

  69. Correction to Funding/Support in: Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry.
    Chest. 2021;160:1989.

  70. GAURAV R, Anderson DR, Radio SJ, Bailey KL, et al
    IL-33 Depletion in COVID-19 Lungs.
    Chest. 2021;160:1656-1659.

    Personalizing Oral Corticosteroid Dose in Severe COPD Exacerbations.
    Chest. 2021;160:1581-1582.

  72. HILL NS, Criner GJ, Branson RD, Celli BR, et al
    Optimal NIV Medicare Access Promotion: Patients With COPD: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic
    Chest. 2021;160:e389-e397.
    PubMed     Abstract available

  73. GERSHON AS, Pequeno P, Alberga Machado A, Aaron SD, et al
    Factors Associated With Nonreceipt of Recommended COPD Medications: A Population Study.
    Chest. 2021;160:1670-1680.
    PubMed     Abstract available

  74. LI L, Zhao N, Ma X, Sun F, et al
    Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbations of COPD: A Prospective, Multicenter, Randomized, Open-Label Clinical Trial.
    Chest. 2021;160:1660-1669.
    PubMed     Abstract available

    October 2021
  75. SAFIRI S, Carson-Chahhoud K, Karamzad N, Sullman MJM, et al
    Prevalence, deaths and disability-adjusted-life-years (DALYs) due to asthma and its attributable risk factors in 204 countries and territories, 1990-2019.
    Chest. 2021 Oct 23. pii: S0012-3692(21)04206-9. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  76. RUPANI H, Kent BD
    Using FeNO Measurement in Clinical Asthma Management.
    Chest. 2021 Oct 18. pii: S0012-3692(21)04109-X. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  77. MENDEZ R, Feced L, Alcaraz-Serrano V, Gonzalez-Jimenez P, et al
    Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.
    Chest. 2021 Oct 14. pii: S0012-3692(21)04101-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  78. LEUNG C, Sin DD
    Asthma-COPD Overlap: What are the important questions?
    Chest. 2021 Oct 6. pii: S0012-3692(21)04078-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  79. ZAFAR MA, Sengupta R, Bates A, Woods JC, et al
    Oral Positive Expiratory Pressure Device for Excessive Dynamic Airway Collapse Caused by Emphysema.
    Chest. 2021;160:e333-e337.
    PubMed     Abstract available

  80. BERTELS X, Lahousse L
    Benefits of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers on Progression of Emphysema and Lung Function Decline.
    Chest. 2021;160:1160-1162.

  81. KANTAR A
    Bronchiectasis in Australian First Nations Children: Looking Inside the Gunyah.
    Chest. 2021;160:1153-1154.

  82. AKUTHOTA P, Jackson DJ, Wechsler ME
    Introducing the Severe Asthma Series of Invited Reviews.
    Chest. 2021;160:1151-1152.

  83. MARCIANO BE, Olivier KN, Folio LR, Zerbe CS, et al
    Pulmonary Manifestations of GATA2 Deficiency.
    Chest. 2021;160:1350-1359.
    PubMed     Abstract available

  84. WANG MT, Lai JH, Huang YL, Liou JT, et al
    Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting beta2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting beta2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity S
    Chest. 2021;160:1255-1270.
    PubMed     Abstract available

  85. GLASSBERG MK, Csete I, Simonet E, Elliot SJ, et al
    Stem Cell Therapy for COPD: Hope and Exploitation.
    Chest. 2021;160:1271-1281.
    PubMed     Abstract available

    September 2021
  86. ZOU RH, Bon J
    Reduced Dlco in GOLD I COPD: Moving Towards a Multidimensional Approach to Risk Stratification.
    Chest. 2021;160:791-792.

  87. YOSHIDA M, Miyahara Y, Orimo K, Kono N, et al
    Eosinophil Extracellular Traps in the Casts of Plastic Bronchitis Associated With Influenza Virus Infection.
    Chest. 2021;160:854-857.

  88. DE-TORRES JP, O'Donnell DE, Marin JM, Cabrera C, et al
    Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD.
    Chest. 2021;160:872-878.
    PubMed     Abstract available

  89. WU TD, Fawzy A, Brigham E, McCormack MC, et al
    Association of Triglyceride-Glucose Index and Lung Health: A Population-Based Study.
    Chest. 2021;160:1026-1034.
    PubMed     Abstract available

    August 2021
  90. HEIDORN MW, Steck S, Muller F, Trobs SO, et al
    Forced expiratory volume in one second predicts cardiac status and outcome in chronic heart failure.
    Chest. 2021 Aug 17. pii: S0012-3692(21)03682.
    PubMed     Abstract available

  91. TATAH J, Keen JL, Prisco SZ, Pritzker M, et al
    Iron Deficiency is Associated with More Severe Pulmonary Vascular Disease in Pulmonary Hypertension due to Chronic Lung Disease.
    Chest. 2021 Aug 2. pii: S0012-3692(21)03610-2. doi: 10.1016/j.chest.2021.07.2159

    Treatment of Pulmonary Hypertension Associated With COPD: Time for Another Look?
    Chest. 2021;160:409-410.

  93. DECATO TW, Hegewald MJ
    Diffusing Capacity, the Too Often Ignored Lung Function Test in COPD.
    Chest. 2021;160:389-390.

  94. SOLED DR, Thurber E, Amundson B, Schissel SL, et al
    Payment Reform as a Means of Achieving Justice: A Look at Pulmonary Rehabilitation Reimbursement.
    Chest. 2021;160:786-788.

  95. CASANOVA C, Gonzalez-Davila E, Martinez-Gonzalez C, Cosio BG, et al
    Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex.
    Chest. 2021;160:481-490.
    PubMed     Abstract available

  96. MAHLER DA, Halpin DMG
    Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD.
    Chest. 2021;160:491-498.
    PubMed     Abstract available

    July 2021
  97. CHONG WH, Saha B, Ibrahim A, Smith TC, et al
    Dyspnea in a 57-Year-Old Man With Recent Viral Illness.
    Chest. 2021;160:e19-e24.
    PubMed     Abstract available

  98. PISTELLI F, Carrozzi L
    Slow Is Better Than Fast?: Usefulness of FEV1/Slow Vital Capacity <0.7 in the Identification of Asymptomatic Ever Smokers at Risk for COPD.
    Chest. 2021;160:7-8.

  99. DEMEO DL
    Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.
    Chest. 2021;160:104-113.
    PubMed     Abstract available

  100. FORTIS S, Comellas AP, Bhatt SP, Hoffman EA, et al
    Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
    Chest. 2021;160:94-103.
    PubMed     Abstract available

    June 2021
  101. BUTLER SJ, Gershon AS, Goodridge DM
    Perspectives on Palliative Care in COPD.
    Chest. 2021;159:2133-2134.

  102. DIVO M
    Increased Health Care Use: With or From COPD?
    Chest. 2021;159:2131-2132.

  103. SHEN E, Lee JS, Mularski RA, Crawford P, et al
    COPD Comorbidity Profiles and 2-Year Trajectory of Acute and Postacute Care Use.
    Chest. 2021;159:2233-2243.
    PubMed     Abstract available

  104. SERBAN KA, Pratte KA, Bowler RP
    Protein Biomarkers for COPD Outcomes.
    Chest. 2021;159:2244-2253.
    PubMed     Abstract available

  105. FU Y, Mason A, Boland AC, Linklater G, et al
    Palliative Care Needs and Integration of Palliative Care Support in COPD: A Qualitative Study.
    Chest. 2021;159:2222-2232.
    PubMed     Abstract available

    May 2021
  106. CHANDRA D, Gupta A, Kinney GL, Fuhrman CR, et al
    The Association between Lung Hyperinflation and Coronary Artery Disease in Smokers.
    Chest. 2021 May 7. pii: S0012-3692(21)00889-8. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

  107. CHONG WH, Saha B, Shkolnik B
    Persistent Dyspnea in a 74-Year-Old Man With Normal Spirometry and Lung Volumes.
    Chest. 2021;159:e303-e307.
    PubMed     Abstract available

  108. HAZELETT BN, Paton A, Majid A, Schreefer K, et al
    Nurse Coordinator Roles and Responsibilities for Bronchoscopic Lung Volume Reduction With Endobronchial Valves.
    Chest. 2021;159:2090-2098.
    PubMed     Abstract available

  109. NYBERG A, Martin M, Saey D, Milad N, et al
    Effects of Low-Load/High-Repetition Resistance Training on Exercise Capacity, Health Status, and Limb Muscle Adaptation in Patients With Severe COPD: A Randomized Controlled Trial.
    Chest. 2021;159:1821-1832.
    PubMed     Abstract available

    April 2021
  110. DAY K, Ostridge K, Conway J, Cellura D, et al
    Interrelationships Among Small Airways Dysfunction, Neutrophilic Inflammation, and Exacerbation Frequency in COPD.
    Chest. 2021;159:1391-1399.
    PubMed     Abstract available

  111. SAEED GJ, Valero-Elizondo J, Mszar R, Grandhi GR, et al
    Prevalence and Disparities in Influenza Vaccination Among Patients With COPD in the United States.
    Chest. 2021;159:1411-1414.

  112. ZAFARI Z, Li S, Eakin MN, Bellanger M, et al
    Projecting Long-term Health and Economic Burden of COPD in the United States.
    Chest. 2021;159:1400-1410.
    PubMed     Abstract available

    February 2021
  113. VIZZA CD, Hoeper MM, Huscher D, Pittrow D, et al
    Pulmonary hypertension in patients with chronic obstructive lung disease: results from COMPERA.
    Chest. 2021 Feb 10. pii: S0012-3692(21)00272-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available

    November 2020
  114. YOUNG RP, Hopkins RJ, Gamble GD, Silvestri GA, et al
    Incorporating baseline lung function in lung cancer screening: Does a "lung health check" help predict outcomes?
    Chest. 2020 Nov 7. pii: S0012-3692(20)35129-1. doi: 10.1016/j.chest.2020.

    August 2020
  115. KAVANAGH JE, Hearn AP, Dhariwal J, Grainne d'Ancona, et al
    Real World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
    Chest. 2020 Aug 31. pii: S0012-3692(20)34313.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.